Invea Therapeutics, Inc

CIK 1906425 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Invea Therapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Mar 6, 2026RW0001213900-26-024644
Jan 30, 2026EFFECT9999999995-26-000394
Jan 27, 2026S-1/A0001213900-26-008321
Jan 23, 2026S-1/A0001213900-26-007338
Jan 9, 2026FWP0001213900-26-003023
Jan 7, 2026S-1/A0001213900-26-001947
Dec 15, 2025S-10001213900-25-121387
Dec 10, 2025D0001906425-25-000004
Apr 9, 2025D0001906425-25-000001
Mar 29, 2024RW0001104659-24-041142
Jan 26, 2024S-1/A0001104659-24-007237
Jan 12, 2024S-1/A0001104659-24-003696
Oct 20, 2023S-10001104659-23-110477
Apr 22, 2022D0001906425-22-000001